R. Moreno et al., Intrapericardial beta-adrenergic blockade with esmolol exerts a potent antitachycardic effect without depressing contractility, J CARDIO PH, 36(6), 2000, pp. 722-727
Citations number
28
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Hyperadrenergic states of various etiologies can contribute to tachycardias
. Systemic beta -adrenergic blockade suppresses sinus tachycardia but may a
dversely affect arterial blood pressure and contractility, because the drug
gains access to myocardial cells as well as to the sinoatrial node. We exa
mined whether intrapericardial beta -adrenergic blockade with esmolol could
suppress tachycardia without reducing contractility as a result of limited
drug diffusion, which would be sufficient to penetrate the superficial sin
oatrial node but not the deeper myocardial layers. In five anesthetized pig
s, we provoked a reflex heart rate increase of 50 beats/min with hemorrhage
. The rapidly acting beta -adrenergic blocking agent esmolol (1 mg/kg) was
administered intrapericardially using a new percutaneous transatrial access
method and a catheter system that can be rapidly and safely introduced. Es
molol equivalently suppressed hemorrhage-induced sinus tachycardia when adm
inistered intrapericardially (from 192 to 158 beats/min at 5 min, p < 0.05)
or intravenously (from 177 to 151 beats/min at 1 min, p < 0.05). The antit
achycardic effect of intrapericardial esmolol was prolonged compared with i
ntravenous esmolol (10 min vs. 3 min, p < 0.05). Intrapericardial esmolol d
id not affect blood pressure or left ventricular dP/dt max, an index of con
tractility, whereas intravenous esmolol decreased blood pressure at 1 min f
or 2 min (p < 0.05) and simultaneously decreased left ventricular dP/dt max
at 1 min for < 2 min (p < 0.05). Intrapericardial esmolol suppresses adren
ergically induced sinus tachycardia without decreasing contractility or blo
od pressure. The transatrial approach for intrapericardial delivery of cert
ain beta -adrenergic blocking agents could be employed to control tachycard
ias in emergency care and surgical settings in patients with impaired cardi
ac contractility and propensity to hypotension.